Element Biosciences
E1472104
UNEXPLORED
Element Biosciences is a biotechnology company that develops next-generation DNA sequencing platforms and technologies for genomic research.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Element Biosciences canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T21206815 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Element Biosciences Context triple: [John Stuelpnagel, boardMemberOf, Element Biosciences]
-
A.
BD Biosciences
BD Biosciences is a biotechnology company that develops and supplies research and clinical tools, including cell analysis instruments, reagents, and culture media, for life science and medical laboratories worldwide.
-
B.
Corning Life Sciences
Corning Life Sciences is a division of Corning that develops and manufactures laboratory consumables and equipment used in cell culture, genomics, drug discovery, and other life science research applications.
-
C.
Molecular Devices
Molecular Devices is a life sciences company that develops and manufactures analytical instruments and software for high-throughput screening, cellular imaging, and microplate detection used in biological research and drug discovery.
-
D.
New England Biolabs
New England Biolabs is a biotechnology company renowned for producing molecular biology reagents, particularly restriction enzymes and DNA-modifying tools used in research laboratories worldwide.
-
E.
Quanterix
Quanterix is a biotechnology company specializing in ultra-sensitive digital immunoassay technologies for biomarker detection and precision health diagnostics.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Element Biosciences Target entity description: Element Biosciences is a biotechnology company that develops next-generation DNA sequencing platforms and technologies for genomic research.
-
A.
BD Biosciences
BD Biosciences is a biotechnology company that develops and supplies research and clinical tools, including cell analysis instruments, reagents, and culture media, for life science and medical laboratories worldwide.
-
B.
Corning Life Sciences
Corning Life Sciences is a division of Corning that develops and manufactures laboratory consumables and equipment used in cell culture, genomics, drug discovery, and other life science research applications.
-
C.
Molecular Devices
Molecular Devices is a life sciences company that develops and manufactures analytical instruments and software for high-throughput screening, cellular imaging, and microplate detection used in biological research and drug discovery.
-
D.
New England Biolabs
New England Biolabs is a biotechnology company renowned for producing molecular biology reagents, particularly restriction enzymes and DNA-modifying tools used in research laboratories worldwide.
-
E.
Quanterix
Quanterix is a biotechnology company specializing in ultra-sensitive digital immunoassay technologies for biomarker detection and precision health diagnostics.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.